Company: BLCO
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001860742-25-000018
Chunk: 23

Company: Bausch & Lomb Corp
Filing Date: 2025-07-30
Form: 10-Q
Item: Item 8
Chunk 23
---
 issuances (Level 2).

13

7.INVENTORIESInventories, net consist of:(in millions)June 30,2025December 31,2024Raw materials$262 $262 Work in process85 99 Finished goods704 675 $1,051 $1,036 8.INTANGIBLE ASSETS AND GOODWILLIntangible AssetsThe major components of intangible assets consist of: June 30, 2025December 31, 2024(in millions)GrossCarryingAmountAccumulatedAmortization and ImpairmentsNetCarryingAmountGrossCarryingAmountAccumulatedAmortization and ImpairmentsNetCarryingAmountFinite-lived intangible assets:      Product brands$4,404 $(2,948)$1,456 $4,373 $(2,799)$1,574 Corporate brands102 (22)80 102 (18)84 Product rights/patents1,000 (986)14 993 (970)23 Other80 (67)13 79 (64)15 Total finite-lived intangible assets5,586 (4,023)1,563 5,547 (3,851)1,696 Acquired in-process research and development intangible asset100 — 100 100 — 100 B&L Trademark1,698 — 1,698 1,698 — 1,698 $7,384 $(4,023)$3,361 $7,345 $(3,851)$3,494 Long-lived assets with finite lives are tested for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Impairment charges associated with these assets are included in Other expense, net in the Condensed Consolidated Statements of Operations. Bausch + Lomb continues to monitor the recoverability of its finite-lived intangible assets and tests the intangible assets for impairment if indicators of impairment are present.There were no asset impairments during the six months ended June 30, 2025. Asset impairments during the six months ended June 30, 2024 were $5 million related to a product brand discontinuation. Estimated amortization expense of finite-lived intangible assets for the remainder of 2025 and the five succeeding years ending December 31 and thereafter are as follows:(